DUSA Pharmaceuticals, Inc.
25 Upton Drive
Wilmington
Massachusetts
01887
United States
Tel: 978-657-7500
Fax: 978-657-9193
Website: http://www.dusapharma.com/
About DUSA Pharmaceuticals, Inc.
154 articles about DUSA Pharmaceuticals, Inc.
-
DUSA Resolves Investigation Related to Promotion of Actinic Keratosis Drug
8/24/2020
DUSA Pharmaceuticals, Inc., ("DUSA"), a wholly owned subsidiary of Sun Pharmaceutical Industries, Inc. ("SPII") today announced that it has reached a resolution with the United States Department of Justice (DOJ) concerning the promotion of LEVULAN® KERASTICK® (aminolevulinic acid HCL) and BLU-U®.
-
DUSA Pharmaceuticals, Inc. Awarded Preliminary Injunctive Relief Prohibiting Biofrontera From Using its Trade Secrets
12/26/2018
DUSA Pharmaceuticals, Inc. announced that DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together known as "Biofrontera") from using DUSA's confidential and proprietary trade secret information.
-
DUSA Pharmaceuticals, Inc. Files Lawsuit Against Biofrontera Inc. for Patent Infringement, Trade Secret Misappropriation, and Tortious Interference
7/11/2018
The lawsuit alleges patent infringement of DUSA's patents covering DUSA's product for topical solution, 20% used with DUSA's BLU-U Blue Light Photodynamic Therapy Illuminator.
-
Caraco Pharmaceutical Laboratories, Ltd. Announces Successful Tender Offer to Acquire DUSA Pharmaceuticals
12/20/2012
-
Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals
11/9/2012
-
Sun Pharmaceutical Industries Ltd to Purchase DUSA Pharmaceuticals for $230 Million
11/8/2012
-
DUSA Pharmaceuticals to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call
11/5/2012
-
DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study
9/13/2012
-
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
9/4/2012
-
DUSA Pharmaceuticals Reports Second Quarter 2012 Corporate Highlights and Financial Results
8/2/2012
-
DUSA Pharmaceuticals to Host Second Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call
7/26/2012
-
DUSA Pharmaceuticals to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City
6/15/2012
-
DUSA Pharmaceuticals to Webcast Annual Meeting of Shareholders
6/7/2012
-
DUSA Pharmaceuticals to Present at the Jefferies and Co. 2012 Global Healthcare Conference
5/31/2012
-
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results
5/8/2012
-
DUSA Pharmaceuticals to Host First Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call
5/1/2012
-
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R) Kerastick(R) Photodynamic Therapy
4/24/2012
-
DUSA Pharmaceuticals Introduces Teeing Off Against Sun Damage(TM) Campaign to Raise Awareness of Actinic Keratosis
4/10/2012
-
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
3/23/2012
-
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
3/19/2012